Wills Eye at ARVO

The Association for Research in Vision and Ophthalmology (ARVO) is the leading international research organization for the vision research community.  The annual meeting is the largest meeting of basic and clinical researchers from around the world who come to together to share novel and cutting-edge breakthroughs in eye and vision research. Wills Eye faculty, staff and trainees actively participate at ARVO each year, contributing to new knowledge and ideas to advance prevention and treatment of eye diseases and patient care. This year, at the 2018 ARVO Annual Meeting in Honolulu, Hawaii, Wills Eye faculty, staff, fellows, residents and medical students will give 22 presentations (2 papers and 20 posters) are co-authors on an additional 12 presentations (4 paper and 8 poster).

Sunday April 29, 2018
RE: Diabetic Retinopathy Clinical3:30 – 3:45 PM
Room 311
Presentation # 736
Hsu J , Obeid A , Su D , Uhr J , Patel SOutcomes in proliferative diabetic retinopathy patients who are lost to follow-up after panretinal photocoagulation vs. intravitreal anti-vascular endothelial growth factor injection
Monday April 30, 2018
RE: Vitreoretinal Interface and Retinal Detachment9:15 – 9:30 AM
Room 311
Presentation # 1160
Yiu G, Emami-Naeini P, Deaner J , Ali F , Gogte P, Kaplan R, Chen K, Nudleman E, Singh Grewal D, Gupta M, Wolfe J, Klufas M  Experience and Outcomes of Pneumatic Retinopexy Performed by Vitreoretinal Fellows in the United States
RE: Vitreoretinal Interface and Retinal Detachment9:45 – 10:00 AM
Room 311
Presentation # 1162
Rodriguez M, Ryan E, Ryan C, Kakulavarapu S, Mardis P, Stefater J, Forbes N, Gupta O , Capone A, Joseph D, Eliott D, Yonekawa YImpact of Viewing System Choice During Primary Retinal Detachment Repair
Wednesday May 2, 2018
CL: Impact of Vision Impairment12:30 -12:45 PM
Room 316B
Presentation # 4465
De Moraes C, Liebmann J, Boland M, Myers J , Wellik S, Elze T, Ritch R, Hood DRates of Global and Central Visual Field Change and Visual Impairment from Glaucoma in the US: The Glaucoma Research Network (GRN)
Thursday May 3, 2018
GL: Visual Fields, Vision Function, Psychophysics11:15 – 11:30 AM
Ballroom A
Presentation #6028
Li D, Pasquale L, Shen L, Boland M, Wellik S, De Moraes C, Myers J , Baniasadi N, Wang H, Bex P, Elze T, Wang MA New Method to Detect Visual Field Progression based on Spatial Pattern Analysis
RE: Retinal Vascular Diseases II12:00 - 12:15 PM
Room 311
Presentation #5972
Sioufi K, Obeid A, Bekerman V, Ferenczy S, Hsu J, Shields CQuantification of Optical Coherence Tomography Angiography Metrics and their Relationship to Visual Acuity in Eyes Treated with Plaque Radiotherapy for Uveal Melanoma
Sunday April 29, 2018
RE: AMD and Retinal Therapies Excluding Anti-VEGF8:15-10:00 AM
Poster # A0126
Storey P , Obeid A , Pancholy M, Goodman J, Gao X , Borkar D , Su D , Regillo C  Incidence of Ocular Hypertension Following Intravitreal Injection of 2mg Triamcinolone
RE: Vitreoretinal Surgery: Clinical Science3:15 – 5:00 PM Poster # A0198Su D, Obeid A, Hsu JTopical Aqueous Suppression and Spontaneous Closure of Idiopathic Full-Thickness Macular Holes
Monday April 30, 2018
CO: Corneal Surgery Non-Refractive8:15-10:00 AM
Poster # B0046
Kanesa-Thasan A, Nguyen M, Ayres B  Analysis of Visual and Refractive Outcomes of Scleral-Fixated Intraocular Lens Implants
RE: Clinical Retina Imaging8:15-10:00 AM
Poster # C0343
Weiss S, Stathopoulos C, Shields CChoroidal Nevus with Retinal Invasion in 8 Cases
AP: Retinoblastoma: From Bench to Bedside11:15-1:00 PM
Poster # A0022
Dalvin L, Ancona-Lazama D, Lucio-Alvarez J, Jabbour P, Shields C  Ophthalmic Vascular Events following Primary Intra-arterial Chemotherapy for Retinoblastoma Analysis of 243 Infusions of 76 Eyes at a Single Center
Tuesday May 1, 2018
CL: Glaucoma Risk Factors, Progression, and Management8:15-10:00 AM
Poster # B0116
Nayak Kolomeyer N, Hark L, Katz LJ, Myers J, Lee D, Razeghinejad MR, Leite S, Rahmatnejad K, Zhan T, Leiby B, Hegarty S, Lee P  Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Interphysician Agreement for Screening Images
RE: Diabetic Macular Edema Anti-VEGF3:30-5:15 PM
Poster # A0222
Ali F, Obeid A, Borkar D, Garg S, Ho A, Vander J, Hsu JTrends in the use of Anti-VEGF Intravitreal Injections for the Treatment of Diabetic Macular Edema (DME) Across the United States from 2013-2017
AP: Melanoma: Clinical Innovations3:30-5:15 PM
Poster # A0284
Shah S, Correa Z, Schefler A, Kogachi K, Aronow M, Callejo S, Day S, Paton K, Phan I, Shields C , Skalet A, Jennelle R, Berry JTrends in Radiation Practices for Female Ocular Oncologists in North America
AP: Melanoma: Clinical Innovations3:30-5:15 PM
Poster # A0299
Yu M, Dalvin L, Shields CClinical Features and Multimodal Imaging Characteristics of Choroidal Nevi in Pediatric Patients
AP: Melanoma: Clinical Innovations3:30-5:15 PM
Poster # A0307
Surakiatchanukul W, Srinivasan A, Shields CUveal Melanoma-Associated Pain: Clinical Features and Pain Characteristics
RE: ROP23:30-5:15 PM
Poster # B0173
Patel S, Gupta M, Rusu I, Yonekawa Y, Jonas K, Oltra E, Orlin A, Chang J, Horowitiz J, Capone A, Chan REarly Diagnosis and Management of Aggressive Posterior Neonatal Vitreoretinopathy Presenting in Premature Neonates
LV: Profound Low Vision and Low-Vision Clinical Trials3:30-5:15 PM
Poster # C0367
Sergott R, Scannell Bryan M, Blouin L, Katz BBaseline Structural and Psychophysical Profiles of Subjects Enrolled in Phase 3 Trials with rAAV2/2-ND4, an Investigational Gene Therapy for ND4LHON
Wednesday May 2, 2018
RE: Retinal Detachment: Basic and Clinical Science8:15-10:00 AM
Poster # C0093
Obeid A, Ehmann D, Adam M, Kasi S, Klufas M, Hsu J, Mehta S, Chiang A, Garg S, Gupta OComparison of Residual Subfoveal Fluid by Intraoperative Optical Coherence Tomography After Macula Involving Rhegmatogenous Retinal Detachment Repair Using Direct Drainage, Drainage Retinotomy, or Perfluoro-n-Octane
RE: Retinal Vascular Diseases I (excluding diabetes)8:15-10:00 AM
Poster # C0162
Rayess N, Rahimy E, Ying G, Pefkianaki M, Regillo C, Ho A, Hsu JBaseline Choroidal Thickness as a Predictor for Treatment Outcomes in Branch Retinal Vein Occlusion
AP: Ocular Complications of Therapy: Trends, Imaging, Treatment8:15-10:00 AM
Poster # C0276
Pefkianaki M, Mashayekhi A, Taylor D, Isaacoff E, Shields J, Shields CFactors Predictive of Development of Cystoid Macular Edema Following Plaque Radiotherapy of Uveal Melanoma
RE: Cataract Surgery Outcomes and Epidemiology11:15-1:00 PM
Poster # B0415
Moustafa G, Borkar D , McKay M, Eton E, Koulisis N, Lorch A, Kloek COutcomes in Resident Performed Cataract Surgeries with Iris Challenges: Results from the PCIOL Study
RE: Retina/RPE Transplantation (clinical)3:30-5:15 PM
Poster # A0075
Schwartz S, Regillo C , Lam B, Eliott D, Gregori N, Hubschman J, Heilweil G, Spirn M, Maguire J , Ostrick R, Del Priore L, Anglade E, Lanza RHuman Embryonic Stem Cell-Derived Retinal Pigment Epithelial Transplantation for Retinal Degenerations: Three-Year Outcome Data
GL: Electrophysiology and Visual Fields3:30-5:15 PM
Poster # B0096
Wang M, Pasquale L, Shen L, Boland M, Wellik S, De Moraes C, Myers J , Baniasadi N, Li D, Wang H, Bex P, Elze TPredicting Functional Progression in Glaucoma from Baseline Visual Fields
GL: Electrophysiology and
Visual Fields
3:30-5:15 PM
Poster # B0123
Jin Q, Thein T, Pasquale L, Shen L, Boland M, Wellik S, De Moraes G, Myers J , Bex P, Baniasadi N, Li D, Wang H, Wang M, Elze TEffect Modification of Refractive Error on Visual Field Pattern Deviation in Glaucoma
CL: Consequences of and Associations with Vision Impairement3:30-5:15 PM
Poster B209
Wizov S , Waisbourd, Jordan C, Shiuey E, Gianchetti L, Tran J, Sanvicente C, Spaeth GFall Risk in Moderate Glaucoma
CL: Healthcare Delivery3:30-5:15 PM
Poster # B0330
Rostami B, Nguyen-Cuu J, Brown G, Brown M , Sadun A, Sebag JCost-Effectiveness of Limited Vitrectomy for Vision Degrading Vitreopathy
Thursday May 3, 2018
RE: Retinal Vascular Diseases II (excluding diabetes)8:15-10:00 AM
Poster # A0126
Gao X, Borkar D, Storey P, Su D, Obeid A, Sioufi K, Ho A, Garg S, Hsu JIncidence of Retinal Artery Occlusion Following Intravitreal Anti-Vascular Endothelial Growth Factor Injections
AP: Lymphoma, Hemangioma, Surface, Orbit, and Eyelid Tumors8:15-10:00 AM
Poster # A0312
Ang S, Dalvin L, Shields CPlaque Radiotherapy as Treatment for Medulloepithelioma in 6 Cases at a Single Center
AP: Lymphoma, Hemangioma, Surface, Orbit, and Eyelid Tumors8:15-10:00 AM
Poster # A0319
Iyer P, Dalvin L, Elimimian E, Lally S, Shields CCavernous Hemangioma of the Conjunctiva: A Case Series of 4 Patients
AP: Lymphoma, Hemangioma, Surface, Orbit, and Eyelid Tumors8:15-10:00 AM
Poster # A0321
Eliminian E, Marous M, Casey M, Dalvin L, Lally S, Shields CTreatment of Eyelid Squamous Cell Carcinoma and Papilloma with Interferon Alpha-2b
PH: Drug and Gene Delivery Systems8:15-10:00 AM
Poster # A0416
Tauqeer Z, Storey P , Wolfe J, Todorich B, Shah A, Koto T, Abbey A, Morizane Y, Jeng-Miller K, Chen E, Williams P, Shiraga F, Hirakata A, Garg S , Yonekawa YEndophthalmitis Rates of Ranibizumab in Pre-Filled Syringes Compared to Vials
CL: Medical Education, Training, and Telemedicine11:00-12:45 AM
Poster # C0273
Hark L, Katz LJ, Myers J, Haller JPhiladelphia Telemedicine Glaucoma Detection and Follow-Up Study: Adherence to Community Eye Exam Appointments
RE: Trauma and Endophthalmitis11:00-12:45 AM
Poster # C0304
Borkar D, Obeid A, Su D, Storey P, Gao X, Kaiser R, Garg S, Hsu JEndophthalmitis Rates After Bilateral Same Day Intravitreal Anti-VEGF Injections